Scarica l'app Stockscreener
240.38
1.42%
3.37
Dopo l'orario di chiusura:
242.90
2.52
+1.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Precedente Chiudi:
$237.01
Aprire:
$234.77
Volume 24 ore:
928.09K
Relative Volume:
1.02
Capitalizzazione di mercato:
$16.92B
Reddito:
$2.36B
Utile/perdita netta:
$236.10M
Rapporto P/E:
73.15
EPS:
3.286
Flusso di cassa netto:
$382.50M
1 W Prestazione:
-2.07%
1M Prestazione:
-2.11%
6M Prestazione:
-31.87%
1 anno Prestazione:
-4.54%
Intervallo 1D:
$234.66
$241.13
Intervallo di 1 settimana:
$233.29
$247.60
Portata 52W:
$230.05
$354.88
Insulet Corporation Stock (PODD) Company Profile
Nome
Insulet Corporation
Settore
Industria
Telefono
978-600-7000
Indirizzo
100 NAGOG PARK, ACTON, MA
Compare PODD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
240.38 | 16.68B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
112.65 | 190.38B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
365.92 | 139.51B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
91.34 | 116.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.90 | 105.88B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.26 | 47.42B | 6.07B | 1.06B | 1.34B | 1.8063 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Ripresa | TD Cowen | Hold |
| 2026-01-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-16 | Iniziato | Evercore ISI | Outperform |
| 2025-11-19 | Aggiornamento | UBS | Neutral → Buy |
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-09-08 | Ripresa | Oppenheimer | Outperform |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-05-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-07 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-08-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-01 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-07-28 | Iniziato | Wells Fargo | Overweight |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | Iniziato | BofA/Merrill | Neutral |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-12-10 | Iniziato | CFRA | Sell |
| 2019-10-23 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-10-04 | Downgrade | UBS | Buy → Neutral |
| 2019-10-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-06 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-06-10 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-04-20 | Iniziato | Berenberg | Buy |
| 2018-02-22 | Reiterato | Barclays | Overweight |
| 2018-01-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | Iniziato | Barclays | Overweight |
Mostra tutto
Insulet Corporation Borsa (PODD) Ultime notizie
Published on: 2026-03-09 05:40:12 - baoquankhu1.vn
Insulet stock: Is the Omnipod maker your next stealth growth play? - AD HOC NEWS
Insulet Corporation (PODD) Finalizes Severance Agreement with Fo - GuruFocus
Fisher Asset Management LLC Has $14.29 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Insulet Finalizes Severance Terms for Departing CFO - TipRanks
Former Insulet (NASDAQ: PODD) CFO Ana Chadwick signs severance deal - Stock Titan
Mass. biotech giants added workers in 2025 despite industry-wide layoffs - The Business Journals
Insulet (PODD) SVP Prem Singh reports tax-withholding share transactions - Stock Titan
Insulet (PODD) SVP uses 253 shares to cover RSU tax withholding - Stock Titan
Insulet (PODD) executive records Form 4 tax-withholding share dispositions - Stock Titan
Insulet Corp (NASDAQ: PODD) SVP withholds 605 shares for taxes - Stock Titan
Insulet (PODD) EVP and COO logs tax-withholding share moves in Form 4 - Stock Titan
Insulet Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Segall Bryant & Hamill LLC Boosts Position in Insulet Corporation $PODD - MarketBeat
CI Investments Inc. Grows Stock Position in Insulet Corporation $PODD - MarketBeat
William Blair Investment Management LLC Sells 289,636 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation (PODD) Stock Analysis: Exploring a Promising 43.71% Upside in the Medical Devices Sector - DirectorsTalk Interviews
TD Asset Management Inc Has $12.22 Million Stake in Insulet Corporation $PODD - MarketBeat
Insulet Corporation (NASDAQ:PODD) Short Interest Down 21.8% in February - MarketBeat
Insulet Corporation $PODD Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Strong Revenue Growth And Upbeat 2026 Outlook Might Change The Case For Investing In Insulet (PODD) - simplywall.st
PODD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Quantbot Technologies LP Cuts Position in Insulet Corporation $PODD - MarketBeat
American Century Companies Inc. Sells 106,813 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation's 10th Straight Year Above 20% Revenue Growth Raises Expectations - Smartkarma
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Westfield Capital Management Co. LP Sells 11,362 Shares of Insulet Corporation $PODD - MarketBeat
Integrated Advisors Network LLC Purchases 6,177 Shares of Insulet Corporation $PODD - MarketBeat
Primecap Management Co. CA Cuts Stock Position in Insulet Corporation $PODD - MarketBeat
Intech Investment Management LLC Boosts Stock Holdings in Insulet Corporation $PODD - MarketBeat
Andra AP fonden Buys 28,800 Shares of Insulet Corporation $PODD - MarketBeat
Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating - Finviz
Insulet: The Growth Doesn't Stop Here - Seeking Alpha
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet (PODD) SVP Prem Singh receives equity awards and withholds shares for taxes - Stock Titan
Insulet (PODD) SVP granted RSUs, stock options and withholds shares for taxes - Stock Titan
Insulet (PODD) CAO logs RSU grant, options and tax share withholding - Stock Titan
Equity awards and tax withholding for Insulet (PODD) SVP Kapples - Stock Titan
Insulet (NASDAQ: PODD) COO granted stock and options, withholds shares - Stock Titan
Insulet Corp (PODD) grants stock and option awards to HR chief - Stock Titan
Equity awards for INSULET CORP (PODD) EVP & CFO Flavia Pease - Stock Titan
[Form 4] INSULET CORP Insider Trading Activity - Stock Titan
Discipline and Rules-Based Execution in PODD Response - Stock Traders Daily
Eye On Growth: MICHAEL MINOGUE Adds $499K Of Insulet Stock To Portfolio - Benzinga
Insulet (NASDAQ:PODD) Director Michael Minogue Acquires 2,030 Shares of Stock - MarketBeat
Citigroup Inc. Lowers Stake in Insulet Corporation $PODD - MarketBeat
Insulet Hit With Suit Over 401(k) American Century Funds (1) - Bloomberg Law News
Assessing Insulet (PODD) Valuation After Recent Share Price Weakness And High P/E Multiple - simplywall.st
P/E Ratio Insights for Insulet - Benzinga
Fox Run Management L.L.C. Buys 4,813 Shares of Insulet Corporation $PODD - MarketBeat
Auditor shift at Insulet (NASDAQ: PODD) as Grant Thornton exits - Stock Titan
Insulet Corporation Azioni (PODD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):